Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2019:48 Suppl 1:17-21.
doi: 10.1159/000503876. Epub 2019 Nov 21.

Factors Affecting Intermittent Infusion Hemodiafiltration

Affiliations
Clinical Trial

Factors Affecting Intermittent Infusion Hemodiafiltration

Kenji Eiki et al. Blood Purif. 2019.

Abstract

Background: Intermittent infusion hemodiafiltration -(I-HDF) has been performed for a number of years since this mode of dialysis became available with dialyzers used in Japan. It has been effective in some cases and ineffective in others. In this study, we analyzed and clarified these differences.

Summary: We conducted a retrospective study to determine the factors affecting the effectiveness of I-HDF treatment in some patients and ineffectiveness in others and classified the complex causes associated with volume load that were identified. Key Messages: Bolus dialysate infusion in I-HDF affects the volume load (preload), and repeated bolus dialysate infusion influences both preload and afterload in patients with valvular heart disease. In this study, I-HDF was effective when brain natriuretic peptide levels, cardiothoracic ratio, and ultrafiltration rate were well controlled and cardiac load was low. I-HDF was shown to be effective in patients who are prone to developing hypotension at the end of a dialysis session. There were several factors, including different types of load, involved in inefficiency of I-HDF.

Keywords: Arteriosclerosis obliterans; Cardiothoracic ratio; Dialysis; Intermittent infusion hemodiafiltration; Valvular heart disease.

PubMed Disclaimer

Publication types

Substances

LinkOut - more resources